Abacus Life (NASDAQ:ABL – Get Free Report) had its price objective reduced by B. Riley Financial from $16.00 to $15.00 in a note issued to investors on Monday, Stock Target Advisor reports. The firm currently has a “buy” rating on the stock. B. Riley Financial’s target price suggests a potential upside of 73.41% from the stock’s previous close.
Separately, B. Riley reiterated a “buy” rating and set a $15.00 price target (down from $16.00) on shares of Abacus Life in a report on Monday.
View Our Latest Stock Report on ABL
Abacus Life Trading Up 1.6 %
Abacus Life (NASDAQ:ABL – Get Free Report) last announced its quarterly earnings results on Monday, May 13th. The company reported $0.11 earnings per share (EPS) for the quarter. The business had revenue of $21.49 million during the quarter. Abacus Life had a return on equity of 4.96% and a net margin of 0.11%. As a group, equities research analysts forecast that Abacus Life will post 0.52 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Abacus Life
Several institutional investors have recently made changes to their positions in the company. Barclays PLC acquired a new stake in Abacus Life in the 3rd quarter worth approximately $47,000. Inscription Capital LLC acquired a new stake in Abacus Life in the 1st quarter worth approximately $137,000. Finally, Quarry LP acquired a new stake in Abacus Life in the 4th quarter worth approximately $463,000.
About Abacus Life
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Featured Articles
- Five stocks we like better than Abacus Life
- 3 Healthcare Dividend Stocks to Buy
- Chipotle Mexican Grill Stock Split: Where Does it Go From Here?
- How to Calculate Return on Investment (ROI)
- Arm Holdings and Micron: Top 2 AI Stocks to Buy and Hold
- Insider Trades May Not Tell You What You Think
- Best Buy Stock May Be Best Bought Before the Holiday Season
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.